Maximum Dose of Benzonatate
The maximum recommended adult dose of benzonatate is 600 mg per day, divided into three doses of 200 mg each, with no single dose exceeding 200 mg 1.
Dosing Guidelines
According to FDA labeling, the standard dosing regimen is 1:
- Usual dose: 100-200 mg three times daily as needed for cough
- Maximum daily dose: 600 mg in three divided doses
- Maximum single dose: 200 mg
- Approved age: Adults and children over 10 years old
Critical Safety Warnings
Do not exceed these maximum doses - overdosage can result in death, with fatalities reported in both adults and children 1. The FDA explicitly warns that overdosage resulting in death may occur in adults, making strict adherence to maximum dosing essential.
Onset and Duration
Benzonatate acts peripherally by anesthetizing stretch receptors in the respiratory tract 1:
- Onset of action: 15-20 minutes
- Duration of effect: 3-8 hours
This pharmacokinetic profile supports the three-times-daily dosing schedule.
Critical Safety Considerations
Overdose Risk
Signs and symptoms of overdose have been reported within 15-20 minutes of ingestion, with death occurring within one hour 1, 2. Serious toxicity includes:
- Seizures (including status epilepticus)
- Cardiac arrest and dysrhythmias
- Coma and CNS depression
- Respiratory arrest
A 20-year poison center review found that intentional exposures resulted in serious adverse effects in 22% of cases, with 2 deaths (0.8%) during the study period 3. Notably, dysrhythmias rather than seizures were the cause of fatalities 4.
Administration Requirements
Capsules must be swallowed whole - never broken, chewed, dissolved, cut, or crushed 1. Release of benzonatate in the mouth produces temporary local anesthesia of oral mucosa and can cause choking. If numbness or tingling of the tongue, mouth, throat, or face occurs, patients should refrain from eating or drinking until numbness resolves.
Missed Dose Protocol
If a dose is missed, skip that dose and take the next dose at the scheduled time. Never take 2 doses at one time 1.
Pediatric Considerations
Safety and effectiveness in children below age 10 have not been established 1. Accidental ingestion resulting in death has been reported in children below age 10, with particular risk in children 2 years and younger 2. The medication must be kept out of reach of children.
Clinical Context
While benzonatate is FDA-approved, the available guidelines for cough management [5-5] do not specifically recommend benzonatate, instead focusing on dextromethorphan, menthol, and sedative antihistamines for acute viral cough. A 2023 systematic review raised concerns about the limited evidence base for benzonatate's effectiveness, noting that its approval was founded on evidence that would not meet current regulatory standards 6.